Cyclooxygenase-2 Expression and Angiogenesis in Gastric Hyperplastic Polyp – Association with Polyp Size
2003; Karger Publishers; Volume: 67; Issue: 1-2 Linguagem: Inglês
10.1159/000069708
ISSN1421-9867
AutoresMayumi Kawada, Hiroshi Seno, Manabu Wada, Katsumasa Suzuki, Naoki Kanda, Takahisa Kayahara, Hirokazu Fukui, Mitsutaka Sawada, Toru Kajiyama, Masahiko Sakai, Tsutomu Chiba,
Tópico(s)Helicobacter pylori-related gastroenterology studies
ResumoBackground: Cyclooxygenase (COX)-2 is the rate-limiting enzyme in prostaglandin synthesis, and plays an important role in tumor enlargement. COX-2 is expressed in human gastric and colorectal tumors, and the expression increases in a tumor size-dependent manner. In the present study, we attempted to examine the COX-2 expression pattern in gastric hyperplastic polyp, a non-tumorous lesion. Patients and Methods: Fifty-eight gastric hyperplastic polyps, obtained by endoscopic polypectomy, were immunostained with anti-COX-2 and antivascular endothelial growth factor (VEGF) antibodies. Microvessel density (MVD) was determined by von Willebrand factor immunostaining. Results: In larger gastric hyperplastic polyps, COX-2 was expressed mainly on the luminal side of the polyp stroma, while it was absent in smaller polyps. A significant correlation between COX-2 immunoreactivity and polyp size was observed (p < 0.01). High VEGF expression and MVD were observed mainly in the same stromal region of the polyps where COX-2 was expressed. Both VEGF expression and MVD were also correlated with polyp size significantly (ps < 0.01). Conclusions: COX-2 expression increased in a size-dependent manner in non-tumorous hyperplastic polyps, suggesting that COX-2 expression is not necessarily linked to epithelial cell transformation. Moreover, COX-2 may participate in polyp enlargement through angiogenesis by promoting VEGF production.
Referência(s)